John C. Jacobs - Sep 13, 2021 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role: President, CEO, Director
Signature: /s/ Christian Ulrich, Attorney-in-fact
Stock symbol: HRMY
Transactions as of: Sep 13, 2021
Transactions value $: -$692,763
Form type: 4
Date filed: 9/14/2021, 06:45 PM
Next filing: Dec 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HRMY	Common Stock	Options Exercise	$206K	+25K		$8.22^*	25K	Sep 13, 2021	Direct
transaction	HRMY	Common Stock	Sale	-$898K	-25K	-100%	$35.93	0	Sep 13, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HRMY	Stock Option	Options Exercise	$0	-25K	-7.94%	$0.00	290K	Sep 13, 2021	Common Stock	25K	$8.22	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.45 to $36.38. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The stock option is currently vested with respect to 188,851 shares, and will vest with respect to the remainder of the shares in two equal annual installments beginning on October 1, 2021.